Why Is Actuate Therapeutics ($ACTU) Stock Down -17.99% Today? (Find out why any stock moved today on Tickeron.) ACTU shares tumbled roughly 18% in early trading on October 7, 2026, to about $0.67, down from a prior close of $0.81. The primary catalyst was the company's filing of a Form S-1 to sell up to 50 million shares of common stock, signaling heavy dilution. The registration statement also highlighted a going-concern warning and a Nasdaq listing-standard deficiency notice.
published
Why Is Actuate Therapeutics ($ACTU) Stock Down -17.99% Today? (Find out why any stock moved today on Tickeron.) ACTU shares tumbled roughly 18% in early trading on October 7, 2026, to about $0.67, down from a prior close of $0.81. The primary catalyst was the
$ACTU
Latest documented BWB result
See Billy's timestamped results and follow-through.
Review the latest gains posts, original timestamps, and proof images published by Banking With Billy.
Historical results are not a promise of future performance. Trading involves substantial risk.This public post is a timestamped information archive, not personalized financial advice. Alerts can change as markets move. Join Billy's private group for the complete daily stream and follow-through.